These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34693621)

  • 1. Negative interactions determine Clostridioides difficile growth in synthetic human gut communities.
    Hromada S; Qian Y; Jacobson TB; Clark RL; Watson L; Safdar N; Amador-Noguez D; Venturelli OS
    Mol Syst Biol; 2021 Oct; 17(10):e10355. PubMed ID: 34693621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota interspecies interactions shape the response of Clostridioides difficile to clinically relevant antibiotics.
    Hromada S; Venturelli OS
    PLoS Biol; 2023 May; 21(5):e3002100. PubMed ID: 37167201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in
    Pensinger DA; Dobrila HA; Stevenson DM; Hryckowian ND; Amador-Noguez D; Hryckowian AJ
    mBio; 2024 Mar; 15(3):e0253523. PubMed ID: 38289141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
    Tomkovich S; Stough JMA; Bishop L; Schloss PD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating human gut microbiota interactions that robustly inhibit diverse Clostridioides difficile strains across different nutrient landscapes.
    Sulaiman JE; Thompson J; Qian Y; Vivas EI; Diener C; Gibbons SM; Safdar N; Venturelli OS
    Nat Commun; 2024 Aug; 15(1):7416. PubMed ID: 39198411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
    Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational approaches to understanding Clostridioides difficile metabolism and virulence.
    Jenior ML; Papin JA
    Curr Opin Microbiol; 2022 Feb; 65():108-115. PubMed ID: 34839237
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cheng JKJ; Unnikrishnan M
    Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting Individual Interactions between Pathogenic and Commensal Bacteria within a Multispecies Gut Microbial Community.
    Hassall J; Cheng JKJ; Unnikrishnan M
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33762315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifts in the Gut Metabolome and
    Fletcher JR; Erwin S; Lanzas C; Theriot CM
    mSphere; 2018; 3(2):. PubMed ID: 29600278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jenior ML; Leslie JL; Young VB; Schloss PD
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile.
    Anderson SM; Sears CL
    Clin Infect Dis; 2023 Dec; 77(Suppl 6):S471-S478. PubMed ID: 38051969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capturing the environment of the Clostridioides difficile infection cycle.
    Schnizlein MK; Young VB
    Nat Rev Gastroenterol Hepatol; 2022 Aug; 19(8):508-520. PubMed ID: 35468953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 20. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
    Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
    mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.